Presentation TCT 2020 Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Artery Disease: The Disrupt CAD III Study Presenter: Dean J. Kereiakes October 15, 2020 REGISTER for free or LOG IN to view this content Coronary CAD Pharma Presentation TCT 2020 Disrupt CAD III Dean J. Kereiakes Up Next Presentation TCT 2020 The XIENCE Short DAPT Program: XIENCE 90/28 - Evaluating the Safety of 3-month and 1-month DAPT in HBR Patients Presenter: Roxana Mehran October 15, 2020 More slides + Presentation TCT 2020 1-Year Outcomes of Patients with Residual Physiologic Ischemia After Percutaneous Coronary Intervention: The DEFINE PCI Trial Presenter: Manesh Patel October 15, 2020 Presentation TCT 2020 Three-Year Outcomes of the ULTIMATE Trial Comparing Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation Presenter: Junjie Zhang October 15, 2020 We Recommend
Presentation TCT 2020 The XIENCE Short DAPT Program: XIENCE 90/28 - Evaluating the Safety of 3-month and 1-month DAPT in HBR Patients Presenter: Roxana Mehran October 15, 2020
Presentation TCT 2020 1-Year Outcomes of Patients with Residual Physiologic Ischemia After Percutaneous Coronary Intervention: The DEFINE PCI Trial Presenter: Manesh Patel October 15, 2020
Presentation TCT 2020 Three-Year Outcomes of the ULTIMATE Trial Comparing Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation Presenter: Junjie Zhang October 15, 2020